COLLABORATION AND LICENSE AGREEMENT By and Between IMMUNOGEN, INC. and AVENTIS PHARMACEUTICALS INC.Collaboration and License Agreement • November 14th, 2003 • Immunogen Inc • Pharmaceutical preparations • Delaware
This Collaboration and License Agreement dated as of July 30, 2003 (the “Effective Date”) is by and between ImmunoGen, Inc., a Massachusetts corporation with a principal office at 128 Sidney Street, Cambridge, Massachusetts 02139 (“ImmunoGen”), and Aventis Pharmaceuticals Inc., a Delaware corporation with a principal office at 200 Crossing Boulevard, Bridgewater, New Jersey 08807 (“Aventis”).
